Physician profile
Timothy E Morgan
NPI 1700813953
$793.96
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200 · 2020: $84.37 · 2021: $226 · 2022: $116 · 2023: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $167.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $291.23 | 2019-2023 | |
| Coopersurgical, INC. | $77.73 | 2019-2023 | Paragard T 380a |
| Amag Pharmaceuticals, INC. | $53.02 | 2019-2020 | |
| Therapeuticsmd, INC. | $50.36 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $44.65 | 2023 | Myfembree |
| Merck Sharp & Dohme LLC | $28.28 | 2019 | |
| Davol INC. | $25.17 | 2019 | |
| Sanara Medtech INC. | $23.33 | 2021 | |
| Exeltis, USA INC. | $22.61 | 2021 | |
| Minerva Surgical, INC | $21.16 | 2019 | |
| Myovant Sciences INC. | $20.01 | 2021 | |
| Organon LLC | $17.14 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.31 | 2021 | |
| Shield Therapeutics INC | $13.86 | 2023 | Accrufer |
| Mayne Pharma Commercial LLC | $13.82 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $13.58 | 2019 | |
| Allergan, INC. | $13.20 | 2019 | |
| Daiichi Sankyo INC. | $12.94 | 2022 | |
| Exact Sciences Corporation | $12.85 | 2023 | Cologuard Collection Kit |
| Urovant Sciences INC | $11.47 | 2021 | |
| Ethicon US, LLC | $11.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.